Skip to content
ppharmaranks
Menu

Golimumab-Sldi: uses, dosing, side effects & brands

Golimumab-Sldi is a medicine sold in the U.S. under 2 brand and generic names. Below: what the FDA label says, every product that contains it, what the pills look like, and its recall record.

By the pharmaranks editorial teamReviewed against the FDA (openFDA label, NDC Directory & Enforcement) sourcesUpdated Jul 24, 2026How we research

Key facts

Available as
Injectable
Sold as
2 products — Immgolis and Immgolis Intri
Prescription?
Prescription only
Generic available?
Not in our catalog

Every golimumab-sldi product we track (2)

Same active ingredient — different manufacturer, form, price and FDA recall record. That last one is what our independent score measures.

Golimumab-Sldi products
#DrugRatingPharmacy pays
170/100View →
270/100View →

Related calculators

Frequently asked questions

Can you take golimumab-sldi with other medicines?

It depends on the medicine. We check it against the FDA labels rather than guessing: our interaction checker searches each drug's own label for the other and quotes what it says, naming the section it came from. Run golimumab-sldi against whatever else you take — and remember that a label not naming a drug is not the same as that combination being safe.

What brand names is golimumab-sldi sold under?

We track 2 golimumab-sldi-containing products in the U.S.: Immgolis and Immgolis Intri. They are the same active ingredient; they differ in form, manufacturer, price and FDA recall record.

What forms does golimumab-sldi come in?

Across the brands we track, golimumab-sldi is currently marketed as injectable, per the FDA's National Drug Code Directory. Each form is dosed differently — follow the label for the exact product you were prescribed.

Is there a generic golimumab-sldi?

We do not currently list a generic-labelled golimumab-sldi product. That does not always mean none exists — it means none appears under a generic name in the FDA data we track. Ask your pharmacist.

Cite this page
APA
pharmaranks. (2026, July 24). Golimumab-Sldi: uses, dosing, side effects & brands. https://pharmaranks.com/drugs/golimumab-sldi
MLA
“Golimumab-Sldi: uses, dosing, side effects & brands.” pharmaranks, 24 July 2026, https://pharmaranks.com/drugs/golimumab-sldi.

We summarise public FDA and NIH sources — for a clinical claim, cite the primary source we link to as well.

Sources: FDA openFDA drug label, National Drug Code Directory, and Enforcement (recall) database. This page reproduces public FDA data and is not medical advice. Dosing is set by your prescriber.

Read the full FDA label for golimumab-sldi on DailyMed (NIH) ↗.